Brief: Can-Fite S Namodenoson For Treatment Of Pancreatic Cancer Patients Progress In Clinical Development

Can Fite Biopharma

04/12/2023 13:03

Dec 4 (Reuters) - Can Fite Biopharma Ltd  CANF.TA :
    * CAN-FITE S NAMODENOSON FOR TREATMENT OF PANCREATIC CANCER
PATIENTS: PROGRESS IN CLINICAL DEVELOPMENT
    * CAN FITE BIOPHARMA LTD - STUDY WILL AIM TO ENROLL ABOUT 20
PATIENTS TO ESTABLISH SAFETY AND CLINICAL ACTIVITY

Source text for Eikon:  ID: 
Further company coverage:  CANF.TA 

 ((Reuters.Briefs@thomsonreuters.com;))